Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Nieuwe diagnostische biomarkers voor atypisch parkinsonisme
mei 2019 | Bewegingsstoornissen